MYX 0.23% $4.37 mayne pharma group limited

@Chat:the data for the last four month is very similar and flat...

  1. 81 Posts.
    lightbulb Created with Sketch. 9
    @Chat:the data for the last four month is very similar and flat to the data four month of beginning the year,which is not good ,but not deteriorated in essence.The major generic drug industry in US has been severely challenged.Teva's Q3 did not meet the standard,but Sp rose over40%,because of the good outlook.Our firm believe is to be optimistic about the future developments of MYX.So I think market is over sold.
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.